Geley pharmaceutical announced on April 13 that its wholly-owned subsidiary geley pharmaceutical and China Meheco Group Co.Ltd(600056) Health Products Co., Ltd. ( China Meheco Group Co.Ltd(600056) wholly-owned subsidiary) have signed a distributor agreement to become the distributor of ritonavir tablets of geley pharmaceutical in China.
It is reported that ritonavir tablets are pharmacokinetic enhancers of a variety of oral antiviral drugs against viral protease. Ge Li pharmaceutical has the only ritonavir oral tablet approved for marketing through bioequivalence research in China. The ritonavir oral tablet was approved for marketing by the State Food and Drug Administration in September 2021. GOLLY Pharma has submitted marketing license applications for ritonavir (100 mg film coated tablets) to 12 European countries (Germany, France, Ireland, UK, Spain, Portugal, Italy, Belgium, Poland, Sweden, the Netherlands and Denmark) and Hong Kong, China.
